Aug 19, 2026 · 6 min
Corporate turnarounds meet the smart-city challenge
SK Hynix Rises, Moderna Gains, Estee Lauder Soars as Results Show Turnaround Gaining Steam
The episode links three company-specific market moves with a broader question about how innovation and long-term planning can manage urban growth.
- 1SK Hynix increased shareholder returns through a major buyback and expanded capital-return plans.
- 2Moderna reported encouraging late-stage results for a personalized melanoma vaccine.
- 3Estée Lauder paired stronger sales with improved guidance and restructuring efforts.
Don't miss
The episode’s clearest contrast is between company turnarounds and the long-term planning challenge facing fast-growing cities.
The brief
The episode opens on rapid urbanization, asking how smarter infrastructure and long-term planning can help cities absorb population growth.
Christina Keown and Paul Sweeney examine three market movers: SK Hynix’s buyback and shareholder returns, Moderna’s melanoma-vaccine results, and Estée Lauder’s improving performance.
SK Hynix’s capital-return plans signal confidence in rewarding shareholders, while Moderna’s late-stage personalized-vaccine results offer a potentially important clinical development.
Estée Lauder’s stronger sales, improved guidance, and restructuring efforts provide the clearest turnaround case among the companies discussed.
The closing preview shifts from markets to cities, with Jacob Greaves, Rohit Krishnan, and Estefanía Tapias exploring AI, innovation, and Dubai’s response to rapid growth.
What was said on this episode
7 statements · 6 positive · 1 negative
Investors are increasingly concerned about AI-trade durability and future hyperscaler hardware spending.
“there are signs that investors are becoming more concerned about the durability of the ai trade and how much more harder hardware spending we're going to see from hyperscalers moving forward”
Listen at 1:33
Moderna and Merck achieved the first positive final-stage trial for an mRNA cancer therapy.
“it showed the first positive final stage trial for any mRNA based cancer therapy”
Listen at 2:16
Moderna’s mRNA technology will successfully diversify beyond COVID products.
“the technology that made Moderna household name during the covid era will have a successful second act”
Listen at 2:23
AI will accelerate and compress processes in smart-city systems.
“AI will allow in the smart city space to compress a lot of things. The speed will change.”
Listen at 4:30
Dubai learned substantially from its sudden population increase.
“I think Dubai has learned a lot from a sudden increase in population, which doesn't happen everywhere in the world.”
Listen at 4:49
Dubai responded very effectively to its sudden population increase.
“they reacted very well to it.”
Listen at 4:56
Dubai has a long-term urban-planning vision uncommon worldwide.
“They have a long-term urban planning vision, which again doesn't happen everywhere in the world.”
Listen at 4:58
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
The Closing Bell on the Stock Movers Report
Bloomberg L.P.Books & mentions
Listen to the full episode and explore every guest, topic, and moment on PodLume.